Progesterone, Inhibin, and hcg Multiple Marker Strategy to Differentiate Viable From Nonviable
|
|
- Merilyn Dorsey
- 7 years ago
- Views:
Transcription
1 Progesterone, Inhibin, and hcg Multiple Marker Strategy to Differentiate Viable From Nonviable Pregnancies MAUREEN GLENNON PHIPPS, MD, JOSEPH W. HOGAN, ScD, JEFFREY F. PEIPERT, MD, MPH, GERALYN M. LAMBERT-MESSERLIAN, PhD, JACOB A. CANICK, PhD, AND DAVID B. SEIFER, MD Objective: To determine whether a combination of serum and urine biomarkers drawn from symptomatic pregnant women will help early differentiation of viable from nonviable pregnancies. Methods: We conducted a prospective cohort study of 220 women who presented in the first trimester of pregnancy with complaints of pain, cramping, bleeding, or spotting. Serum samples for progesterone, inhibin A, and hcg, and urine beta-core hcg, were collected at presentation. To evaluate whether those biomarkers could predict viable and nonviable outcomes in pregnancy, we used likelihood ratios to compare operating characteristics of single and multiple biomarker strategies. Results: Of 220 pregnancies studied, 98 were viable and 122 nonviable. Among single biomarkers, progesterone alone appears to have the greatest utility (area under the receiver operator characteristic curve 0.923). Among dualbiomarker strategies, progesterone plus hcg and progesterone plus inhibin A improved specificity but not sensitivity. At 95% sensitivity, the combination of progesterone and hcg improved specificity from 0.29 to 0.66 (improvement 0.37 [95% confidence interval 0.23, 0.52]). A triple-biomarker combination did not show substantial improvement over the dual-biomarker strategy. Also, combinations that used urine beta-core hcg did not improve diagnostic accuracy. From the University of Michigan Health System, Robert Wood Johnson Clinical Scholars Program and Department of Obstetrics and Gynecology, Ann Arbor, Michigan; the Center for Statistical Sciences, Department of Community Health, Brown University, Providence, Rhode Island; Department of Obstetrics and Gynecology and Department of Pathology and Laboratory Medicine, Women and Infants Hospital of Rhode Island, Providence, Rhode Island; and the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Department of Obstetrics and Gynecology, New Brunswick, New Jersey. The following companies provided assay reagents for this study: Diagnostic Products Corp., Los Angeles, California and Chiron Diagnostics Corp., Alameda, California. Conclusion: Serum progesterone appeared to be the single most specific biomarker for distinguishing viable from nonviable pregnancies. When a dual-biomarker strategy was applied, combining serum progesterone with hcg, specificity improved significantly, which suggests that a multiple biomarker strategy might help distinguish viable from nonviable pregnancies in early gestation. (Obstet Gynecol 2000; 95: by The American College of Obstetricians and Gynecologists.) Many biomarkers in serum, including hcg, progesterone, estradiol (E2), alpha-fetoprotein, fetal fibronectin, and inhibin A, have been studied to determine whether they could help diagnose ectopic pregnancies. 1 4 Progesterone s utility as a biomarker has been well demonstrated. 5 7 Inhibin A was shown to be lower in ectopic pregnancies compared with intrauterine pregnancies. 3,8 Urine -core hcg, the major metabolite of hcg in maternal urine, has been studied as a potential biomarker for determining ectopic pregnancies compared with normal pregnancies. 9 Combinations of biomarkers have also been studied to support rapid diagnosis of ectopic pregnancies. 1 The purpose of this study was to determine whether a combination of multiple serum and urine biomarkers from symptomatic women at first-trimester clinical presentation could differentiate a viable from a nonviable pregnancy. We conducted a prospective cohort study of women who presented with complaints of pain, cramping, bleeding, or spotting. Serum quantitative hcg, serum progesterone, serum inhibin A, and urine -core hcg were evaluated independently and in combination to determine their accuracy in predicting viability of a pregnancy. VOL. 95, NO. 2, FEBRUARY /00/$20.00 PII S (99)
2 Materials and Methods We used an observation cohort of 238 pregnant women who presented to the Women and Infants Hospital of Rhode Island urgent care unit between June 1996 and March Women were eligible if they presented with complaints of bleeding, spotting, pain, or cramping in the first trimester (less than 13 weeks gestation). We limited our sample to spontaneously conceived pregnancies. Pregnancy outcomes determined by review of the medical records were known in all subjects included in analysis. Of 238 women initially enrolled, 18 were excluded from analysis because pregnancy outcomes could not be definitively established in 12 and gestational age was unknown in six. Seven women who had therapeutic abortions were included in analysis because there was documentation of a viable pregnancy before termination. The Women and Infants Hospital Institutional Review Board approved the research in June To determine marker values each eligible subject had serum drawn and a urine sample collected at presentation to the urgent care unit. Serum and urine samples were placed in aliquots and frozen at 20C until assays were done. Commercially available assays were used to analyze samples for quantitative hcg (Immulite; Diagnostic Products Corp., Los Angeles, CA), progesterone (Immulite; Diagnostic Products Corp.), inhibin A (enzyme-linked immunosorbant assay by Serotec, Ltd., Oxford, United Kingdom) and urine -core hcg (Titron; Chiron Diagnostics Corp., Alameda, CA). Assays were done without knowledge of pregnancy outcomes and results did not influence treatment. Besides pregnancy status and marker data, we recorded several demographic and historical variables including maternal age, gestational age, gravidity, parity, race, insurance status, and reproductive history. For our primary analysis, we compared operating characteristics (ie, measures of diagnostic accuracy) of progesterone only (P), progesterone plus inhibin A (P I), progesterone plus serum hcg (P H), and progesterone plus serum hcg plus inhibin A (P H I). Our goals were to quantify information gained using multiple biomarker strategies compared with progesterone alone and to determine the nature of differences between single- and multiple-biomarker strategies. Following Haddow et al 10, we used likelihood ratios to quantify the maternal- and gestational-age-adjusted odds of nonviable pregnancies for a given combination of marker values. We used multivariate normal regression models 11 to adjust for variability in biomarkers due to differences in maternal and gestational age and to account for correlations between biomarkers. Spearman nonparametric correlation was determined for each marker combination. We estimated the area under the receiver operator characteristic (ROC) curve based on the likelihood ratios calculated for each screening strategy. To understand the differences between strategies, we compared specificity for given values of sensitivity and compared sensitivity for given values of specificity. For example, because progesterone alone was a very sensitive test, we evaluated various multiple biomarker strategies by comparing their specificity at 95% sensitivity. That involved determining the likelihood ratio cutoff values that corresponded to 95% sensitivity, estimating specificity for the cutoff, and estimating the difference in specificity (and associated 95% confidence interval [CI]) between biomarker combinations. Comparisons of sensitivity at given values of specificity were done similarly. Confidence intervals for the differences in sensitivity and specificity were calculated using the normal approximation to the sampling distribution of each estimated difference, making proper adjustment for within-subject correlation. 12 An important component of our analysis is the calculation of maternal- and gestational-age-adjusted likelihood ratios. Conditional on maternal and gestational age, the likelihood ratio for a woman with a particular set of marker values is the odds that she will have a nonviable pregnancy, denoted by LR Pr(NV M, C)/Pr(V M, C), where Pr(A B) is the conditional probability of A given B, NV and V, respectively, denote nonviable and viable, M represents a set of marker values and C denotes individual characteristics that might affect marker values (maternal and gestational age). Likelihood ratios can be computed by logistic regression, 13 but using correlated markers can lead to loss of efficiency and problems with collinearity. Instead, we computed likelihood ratios by modeling marker distribution separately by viability status. Using Bayes theorem, the likelihood ratio can be expressed in terms of the (multivariate) marker distributions, so that LR [Pr(M NV, C) Pr(NV C)]/[Pr(M V, C) Pr(V C)]. In general, covariates such as maternal and gestational age might affect marker distribution and viability status. We assume that maternal and gestational age do not affect belief about viability status before collecting marker data, the likelihood ratio is proportional to Pr 1 (M NV, C)/Pr 0 (M V, C). The parameters 1 and 0 emphasize that marker values follow separate models by viability status. Individual likelihood ratios are calculated by estimating 1 and 0, then evaluating Pr 1 (M NV, C)/Pr 0 (M V,C) using individual marker values, maternal age, and gestational age. Models for the numerator (NV) and denominator (V) of the likelihood ratios were fit under the assumptions that after a suitable transformation, 228 Phipps et al Multiple Marker Strategy Obstetrics & Gynecology
3 Table 1. Demographic and Clinical Characteristics Characteristic Viable (n 98) Nonviable (n 122) Age (y) Race White 48 (49) 70 (57) Black 27 (28) 20 (16) Hispanic 23 (23) 28 (23) Other 0 (0) 4 (4) Gravidity 1 34 (35) 34 (28) 2 15 (15) 21 (17) 3 49 (50) 67 (55) Parity 0 43 (44) 50 (41) 1 25 (26) 37 (30) 2 30 (31) 35 (29) Symptoms Pain 57 (58) 48 (39) Cramping 34 (35) 53 (43) Bleeding 21 (21) 73 (60) Spotting 22 (22) 34 (28) Table entries are total n (%) except for age, which is mean standard deviation. each set of marker values follows a multivariate normal distribution and that the mean marker value varies linearly with maternal age, possibly up to a cubic function of gestational age. We used natural log transformations for progesterone and inhibin A, and 1/6 power transformation for hcg. The estimated parameters ˆ1 and ˆ0 contain regression parameters, marker standard deviations, and marker correlations for the fitted multivariate models. Each woman s likelihood ratio was computed using LR i f 1 (M i NV, C i )/f 0 (M i V, C i ), where i indexes subject and f is the multivariate normal density function, with dimension equal to the number of markers. Under our assumptions, LR i is proportional to (ie, has the same rank-ordering across individuals as) the odds of having a nonviable pregnancy for a given set of marker values, adjusted for maternal and gestational age. The implication is that it can be used for nonparametric calculations of sensitivity, specificity, and ROC curves. Fitted models used for likelihood ratio calculations were checked using residual plots, and orthogonal Table 2. Biomarker Distribution Percentile Biomarker Nonviable Viable (n 98) (n 122) 25% 50% 75% 25% 50% 75% Serum hcg (IU/mL) ,650 62, , Progesterone (ng/ml) Inhibin A (pg/ml) Urine -core (fmol/ml) polynomials were used to avoid overfitting of the marker distributions to covariates. All analyses were done using SAS Version 6.12 (SAS Institute, Cary, NC); multivariate models were fit using SAS Proc Mixed. Results Pregnancy outcomes included 98 viable intrauterine pregnancies, 85 first-trimester spontaneous abortions, and 37 ectopic pregnancies. Viable intrauterine pregnancies were defined as viable pregnancies (45%); spontaneous abortions and ectopic pregnancies were defined as nonviable pregnancies (55%). The mean age of subjects with viable pregnancies was lower than that of subjects with nonviable pregnancies (24.1 versus 27.9 years, P.01). Other demographic information and clinical characteristics are given in Table 1. There were no significant differences in race, gravidity, or parity. The overall distribution for each biomarker, given outcomes of viable or nonviable pregnancy, was divided into percentiles (Table 2). For progesterone, the viable pregnancy value for the 25th percentile was well above the nonviable pregnancy value at the 75th percentile. There was more overlap between other biomarkers. The greatest disparity between nonviable and viable pregnancies was in the distribution of progesterone values. As a single marker, progesterone had the greatest area under the ROC curve (0.923, compared with for inhibin A, for urine -core hcg, and for serum hcg). In formulating multiple-marker strategies, we chose serum hcg rather than urine -core hcg because the two correlated so strongly (Spearman rank correlation 0.90) and because serum hcg is the biomarker used most commonly by practitioners for evaluating pregnancy viability. For other biomarker combinations, the pairwise rank correlation ranged from 0.32 for progesterone and urine -core hcg to 0.73 for serum hcg and inhibin A. Multiple-marker strategies resulted in improvement in the area under the ROC curve. After incorporating maternal and gestational age adjusted likelihood ratios, the area under the ROC curve for P was.91. When serum hcg was added it increased to.95 (P H), with inhibin A to.94 (P I), and the triple marker combination had an area of.95 (P I H). Area under the ROC curve is a global measure for characterizing utility, and interpreting clinical implications of differences in area under the ROC curve can be difficult. In more detail, we compared sensitivities at fixed specificity, and specificity at fixed sensitivities. Table 3 compares specificity for fixed sensitivities. At 95% sensitivity, the specificity for P was 29%. At the same sensitivity, using the dual biomarker strategy of VOL. 95, NO. 2, FEBRUARY 2000 Phipps et al Multiple Marker Strategy 229
4 Table 3. Estimated Specificity at Given Sensitivity for Biomarker Combinations Sensitivity P P I P H P I H P progesterone alone; P I progesterone plus inhibin A; P H progesterone plus serum hcg; P I H progesterone plus inhibin A plus serum hcg. P I, the specificity increased to 57% and the specificity for P H was 66%. Based on 95% confidence intervals for difference in specificity, those combinations represent statistically significant gains in specificity over P. Specificity for the combination P H was 9% higher than P I (95% CI 0.02, 0.20). Table 4 shows comparisons between specificity for P and combinations with the other biomarkers when sensitivity is 85% and 95%, which indicated that P H is the superior choice. At 95% sensitivity, P I H did not show an appreciable gain in specificity over P H (0.69 compared with 0.66). At 95% specificity, P had sensitivity of 83%. Table 5 shows minimal gains in sensitivity among the various biomarker strategies at fixed specificity values between 0.75 and Discussion We evaluated diagnostic usefulness of biomarkers for distinguishing viable from nonviable early pregnancies in symptomatic women who presented for urgent care. It has been well established that measuring serial serum quantitative hcg is helpful in treating symptomatic women in early gestation. 14 In clinical practice, the time delay necessary for distinguishing a viable from a nonviable pregnancy is often distressing to women and practitioners when women present with symptoms in an emergency setting. Adding serum progesterone to the diagnostic tests can be helpful in clinical management if the level is under 10 ng/ml, suggesting a Table 4. Difference in Specificity Comparison Sensitivity (95% confidence interval) PvsP I 0.01 ( 0.08, 0.06) 0.28 (0.14, 0.43) PvsP H 0.06 ( 0.02, 0.14) 0.37 (0.23, 0.52) P I vsp H 0.07 (0.00, 0.14) 0.09 ( 0.02, 0.20) P progesterone alone; P I progesterone plus inhibin A; P H progesterone plus serum hcg. 95% confidence interval widths adjusted for the six multiple comparisons using the Bonferroni method. Table 5. Estimated Sensitivity at Given Specificity for Biomarker Combinations Specificity P P I P H P I H Abbreviations as in Table 3. nonviable pregnancy, or at least 25 ng/ml, suggesting a viable pregnancy. 4,5 However, in our study, 41% of subjects had progesterone levels in the range of ng/ml. A highly sensitive and specific test to determine viability would be useful in a clinical setting when women present with acute symptoms and a decision regarding treatment must be made quickly. A highly sensitive biomarker more accurately identifies viable pregnancies (true positives) and a highly specific biomarker more accurately identifies nonviable pregnancies (true negatives). Treatment of women who present with cramping and spotting in the first trimester of pregnancy would be better guided by a sensitive and specific test that would reliably categorize prognoses for pregnancies. Thus far, there is no single test that accurately predicts pregnancy outcome in urgent situations. Of the single biomarkers, progesterone has the greatest utility as measured by area under the ROC curve. Although dual-biomarker strategies improved the area under the ROC curve, we found that applying the multiple-biomarker strategies improved specificity but not sensitivity. For improving specificity, the dual biomarker combination progesterone plus serum hcg (P H) is better than progesterone plus inhibin A (P I) and as good as the triple biomarker combination progesterone plus inhibin A plus serum hcg (P I H). The addition of the urine -core hcg was not helpful in this study. Our study had several limitations. It was conducted from a convenience sample of symptomatic women in early gestation who conceived spontaneously. Thus, the results cannot be generalized to asymptomatic pregnant women or women who pursued ovulation induction and assisted reproductive technologies to achieve pregnancy. Our computation of likelihood ratios relied on a (carefully constructed) parametric model to adjust for differences in maternal and gestational ages, both of which have underlying associations with various marker values. The assumptions are needed because of limited sample size. Having data from large, population-based samples would reduce the need to rely on them. 230 Phipps et al Multiple Marker Strategy Obstetrics & Gynecology
5 Our study suggests the need for formalizing a multiple-biomarker strategy for distinguishing viable from nonviable pregnancies. Clinically, that approach might be helpful in prognoses for pregnancies or identifying women with ectopic pregnancy. A study validating our multiple-biomarker screening strategy using a large population database might aid in predicting pregnancy outcomes. References 1. Grosskinsky CM, Hage ML, Tyrey L, Christakos AC, Hughes CL. hcg, progesterone, alpha-fetoprotein, and estradiol in the identification of ectopic pregnancy. Obstet Gynecol 1993;81: Ness RB, McLaughlin MT, Heine RP, Bass DC, Mortimer L. Fetal fibronectin as a biomarker to discriminate between ectopic and intrauterine pregnancies. Am J Obstet Gynecol 1998;179: Seifer DB, Lambert-Messerlian GM, Canick JA, Frishman GN, Schneyer AL. Serum inhibin levels are lower in ectopic than intrauterine spontaneously conceived pregnancies. Fertil Steril 1996;65: Stovall TG, Ling FW, Andersen RN, Buster JE. Improved sensitivity and specificity of a single measurement of serum progesterone over serial quantitative beta-human chorionic gonadotropin in screening for ectopic pregnancy. Hum Reprod 1992;7: Cowan BD, Vandermolen DT, Long CA, Whitworth NS. Receiveroperator characteristic, efficiency analysis, and predictive value of serum progesterone concentration as a test for abnormal gestations. Am J Obstet Gynecol 1992;166: McCord ML, Muram D, Buster JE, Arheart KL, Stovall TG, Carson SA. Single serum progesterone as a screen for ectopic pregnancy: Exchanging specificity and sensitivity to obtain optimal test performance. Fertil Steril 1996;66: Dart R, Dart L, Segal M, Page C, Brancato J. The ability of a single serum progesterone to identify abnormal pregnancies in patients with beta-human chorionic gonadotropin values less than 1,000 miu/ml. Acad Emerg Med 1998;5: D Antona D, Mamers PM, Lowe PJM, Balazs N, Groome NP, Wallace EM. Evaluation of serum inhibin-a as a surveillance biomarker after conservative management of tubal pregnancy. Hum Reprod 1998;12: Cole LA, Kardana A, Seifer DB, Bohler HCL. Urine hcg -subunit core fragment, a sensitive test for ectopic pregnancy. J Clin Endocrinol Metab 1994;78: Haddow JE, Palomaki GE, Knight GJ, Williams J, Miller WA, Johnson A. Screening of maternal serum for fetal Down s syndrome in the first trimester. N Engl J Med 1998;338: Crowder MJ, Hand DJ. Analysis of repeated measures. 1st ed. London: Chapman & Hall, Agresti A. Categorical data analysis. New York: Wiley & Sons, Irwig L. Modeling result-specific likelihood ratios. J Clin Epidemiol 1992;45: Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 5th ed. Baltimore: Williams & Wilkins, Address reprint requests to: Maureen G. Phipps, MD University of Michigan Health System Robert Wood Johnson Clinical Scholars Program 6312 Medical Science Building I 1150 West Medical Center Drive Ann Arbor, MI mphipps@umich.edu Received March 23, Received in revised form June 18, Accepted July 15, Copyright 2000 by The American College of Obstetricians and Gynecologists. Published by Elsevier Science Inc. VOL. 95, NO. 2, FEBRUARY 2000 Phipps et al Multiple Marker Strategy 231
Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in Cases of Habitual Abortions
Prediction of Pregnancy Outcome Using HCG, CA125 and Progesterone in * (MBChB, FICMS, CABOG) **Sawsan Talib Salman (MBChB, FICMS, CABOG) ***Huda Khaleel Ibrahim (MBChB) Abstract Background: - Although
More informationEndocrinology of the Female Reproductive Axis
Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN
More informationMaternal serum free b-hcg and PAPP-A in fetal sex chromosome defects in the rst trimester
PRENATAL DIAGNOSIS Prenat Diagn 2000; 20: 390±394. Maternal serum free b-hcg and PAPP-A in fetal sex chromosome defects in the rst trimester Kevin Spencer 1 *, Natasha Tul 2 and Kypros H. Nicolaides 2
More informationREPRODUCTIVE ENDOCRINOLOGY
FERTILITY AND STERILITY VOL. 82, NO. 5, NOVEMBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. REPRODUCTIVE ENDOCRINOLOGY
More informationSudden Death: Ectopic Pregnancy Mortality
Sudden Death: Ectopic Pregnancy Mortality Frank W. J. Anderson, MD, MPH, Joanne G. Hogan, PhD, and Rudi Ansbacher, MD, MS OBJECTIVE: To describe the trends in ectopic pregnancy mortality in Michigan from
More informationOutcome of Patients with an Indeterminate Emergency Department First-trimester Pelvic Ultrasound to Rule Out Ectopic Pregnancy
912 Tayal et al. d INDETERMINATE US AND ECTOPIC PREGNANCY Outcome of Patients with an Indeterminate Emergency Department First-trimester Pelvic Ultrasound to Rule Out Ectopic Pregnancy Abstract Vivek S.
More informationBUTTE COUNTY PUBLIC HEALTH DEPARTMENT POLICY & PROCEDURE
BUTTE COUNTY PUBLIC HEALTH DEPARTMENT POLICY & PROCEDURE SUBJECT: Pregnancy Testing and Counseling Protocol P&P # APPROVED BY: EFFECTIVE DATE: Mark Lundberg MD Health Officer REVISION DATE: 2/20/2010 Phyllis
More informationNon-Invasive Prenatal Testing (NIPT) Factsheet
Introduction NIPT, which analyzes cell-free fetal DNA circulating in maternal blood, is a new option in the prenatal screening and testing paradigm for trisomy 21 and a few other fetal chromosomal aneuploidies.
More informationPrognosis of Very Large First-Trimester Hematomas
Case Series Prognosis of Very Large First-Trimester Hematomas Juliana Leite, MD, Pamela Ross, RDMS, RDCS, A. Cristina Rossi, MD, Philippe Jeanty, MD, PhD Objective. The aim of this study was to evaluate
More informationStrategies for Identifying Students at Risk for USMLE Step 1 Failure
Vol. 42, No. 2 105 Medical Student Education Strategies for Identifying Students at Risk for USMLE Step 1 Failure Jira Coumarbatch, MD; Leah Robinson, EdS; Ronald Thomas, PhD; Patrick D. Bridge, PhD Background
More informationGuidance for Preconception Care of Women with Thyroid Disease
Before, Between & Beyond Pregnancy The National Preconception Curriculum and Resources Guide for Clinicians Guidance for Preconception Care of Women with Thyroid Disease Avi Alkalay, MD Department of Obstetrics
More informationAdvanced Quantitative Methods for Health Care Professionals PUBH 742 Spring 2015
1 Advanced Quantitative Methods for Health Care Professionals PUBH 742 Spring 2015 Instructor: Joanne M. Garrett, PhD e-mail: joanne_garrett@med.unc.edu Class Notes: Copies of the class lecture slides
More informationyour questions answered the reassurance of knowing A guide for parents-to-be on noninvasive prenatal testing.
your questions answered the reassurance of knowing A guide for parents-to-be on noninvasive prenatal testing. Accurate answers about your baby s health simply, safely, sooner. What is the verifi Prenatal
More informationA. Evidence for an individually adjustable standard to assess birth weight:
Customised antenatal growth charts are designed to facilitate better supervision of fetal growth. The chart is printed out in early pregnancy, after confirmation of pregnancy dates, and allows serial plotting
More informationDifferentiation between normal and abnormal fetal growth
Differentiation between normal and abnormal fetal growth JASON GARDOSI MD FRCSE FRCOG Director, West Midlands Perinatal Institute, St Chad s Court, 213 Hagley Road, Birmingham B16 9RG, U.K. Tel +44 (0)121
More informationABSTRACT LABOR AND DELIVERY
ABSTRACT POLICY Prior to fetal viability, intentionally undertaking delivery of a fetus is the equivalent of abortion and is not permissible. After fetal viability has been reached, intentionally undertaking
More informationAppendices. 2006 Bexar County Community Health Assessment Appendices Appendix A 125
Appendices Appendix A Recent reports suggest that the number of mothers seeking dropped precipitously between 2004 and 2005. Tables 1A and 1B, below, shows information since 1990. The trend has been that
More informationEstimation of Fetal Weight: Mean Value from Multiple Formulas
Estimation of Fetal Weight: Mean Value from Multiple Formulas Michael G. Pinette, MD, Yuqun Pan, MD, Sheila G. Pinette, RPA-C, Jacquelyn Blackstone, DO, John Garrett, Angelina Cartin Mean fetal weight
More informationParvovirus B19 Infection in Pregnancy
Parvovirus B19 Infection in Pregnancy Information Pack Parvovirus B19 Infection in Pregnancy Information Booklet CONTENTS: THE VIRUS page 3 CLINICAL MANIFESTATIONS page 6 DIAGNOSIS page 8 PATIENT MANAGEMENT
More informationFast Track to IVF. Objectives
Disclosure statement: Richard H. Reindollar, M.D. has no relevant financial relationships with any manufacturers of pharmaceuticals, laboratory supplies, or medical devices. Fast Track to IVF Richard H.
More informationCharts of fetal size: limb bones
BJOG: an International Journal of Obstetrics and Gynaecology August 2002, Vol. 109, pp. 919 929 Charts of fetal size: limb bones Lyn S. Chitty a, *, Douglas G. Altman b Objective To construct new size
More informationAcupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection
Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection Sandra L. Emmons, MD Phillip Patton, MD Source: Medical Acupuncture, A Journal For Physicians By Physicians Spring
More informationFact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus Assay. June 17, 2016
Dear Health Care Provider: Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus Assay June 17, 2016 The U.S. Food and Drug Administration (FDA) has issued an Emergency
More informationDeveloping Risk Adjustment Techniques Using the SAS@ System for Assessing Health Care Quality in the lmsystem@
Developing Risk Adjustment Techniques Using the SAS@ System for Assessing Health Care Quality in the lmsystem@ Yanchun Xu, Andrius Kubilius Joint Commission on Accreditation of Healthcare Organizations,
More informationEFFECT OF INCREASED TESTOSTERONE LEVEL ON WOMAN S FERTILITY
1 Nada Polyclinic, Po ega, Croatia 2 School of Medicine, University of Zagreb, Zagreb, Croatia Preliminary Communication Received: April 15, 2004 Accepted: June 16, 2004 EFFECT OF INCREASED TESTOSTERONE
More informationAssessment of Fetal Growth
Assessment of Fetal Growth Unit / Trust: 1. INTRODUCTION The aim of this guideline template is to outline the methods used to assess fetal growth and the referral pathways utilising customised antenatal
More informationMECHANISM OF ACTION. Fertility Awareness-Based Methods. Victoria H. Jennings, PhD Marcos Arevalo, MD, MPH Deborah Kowal, MA, PA
Fertility Awareness-Based Methods Victoria H. Jennings, PhD Marcos Arevalo, MD, MPH Deborah Kowal, MA, PA Fertility awareness helps couples understand how to avoid pregnancy or how to become pregnant.
More informationMotor Vehicle Injuries
Motor Vehicle Injuries Prenatal Counseling about Seat Belt Use during Pregnancy and Injuries from Car Crashes during Pregnancy Background The CDC has identified prevention of motor vehicle injuries as
More informationRationale for replacing IVIG with Intralipid (IL) for immunological pregnancy loss
Rationale for replacing IVIG with Intralipid (IL) for immunological pregnancy loss Recurrent Pregnancy Loss The reason that an embryo may not implant successfully is either because there is something intrinsically
More informationRisk Calculation Software Requirements for Down's Syndrome Screening
Screening Programmes Fetal Anomaly Risk Calculation Software Requirements for Down's Syndrome Screening Version 1 January 2013 Created by: Dave Wright, Barry Nix, Steve Turner, David Worthington and Andy
More information49. INFANT MORTALITY RATE. Infant mortality rate is defined as the death of an infant before his or her first birthday.
49. INFANT MORTALITY RATE Wing Tam (Alice) Jennifer Cheng Stat 157 course project More Risk in Everyday Life Risk Meter LIKELIHOOD of exposure to hazardous levels Low Medium High Consequences: Severity,
More informationWhat is the diagnostic value of ultrasound for determining a viable intrauterine pregnancy?
What is the diagnostic value of ultrasound for determining a viable intrauterine pregnancy? Full citation Sample size Tests Methods Results Limitations Steinkampf,M.P., Guzick,D.S., Hammond,K.R., Blackwell,R.E.,
More informationVitamin D Status: United States, 2001 2006
Vitamin D Status: United States, 2001 2006 Anne C. Looker, Ph.D.; Clifford L. Johnson, M.P.H.; David A. Lacher, M.D.; Christine M. Pfeiffer, Ph.D.; Rosemary L. Schleicher, Ph.D.; and Christopher T. Sempos,
More informationAdequacy of Biomath. Models. Empirical Modeling Tools. Bayesian Modeling. Model Uncertainty / Selection
Directions in Statistical Methodology for Multivariable Predictive Modeling Frank E Harrell Jr University of Virginia Seattle WA 19May98 Overview of Modeling Process Model selection Regression shape Diagnostics
More informationPregnancy and Mental Health Care Among Military Veterans
Pregnancy and Mental Health Care Among Women Veterans Returning from Iraq and Afghanistan Kristin M. Mattocks 12 1,2, Melissa Skanderson 12 1,2, Joseph Goulet 1,2, Sally Haskell 1,2, Elizabeth Yano 3,4,
More informationIn the mid-1960s, the need for greater patient access to primary care. Physician Assistants in Primary Care: Trends and Characteristics
Physician Assistants in Primary Care: Trends and Characteristics Bettie Coplan, MPAS, PA-C 1 James Cawley, MPH, PA-C 2 James Stoehr, PhD 1 1 Physician Assistant Program, College of Health Sciences, Midwestern
More informationSecond-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience
ACTA BIOMED 2007; 78: 214-219 Mattioli 1885 O R I G I N A L A R T I C L E Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years
More informationTHE RISK DISTRIBUTION CURVE AND ITS DERIVATIVES. Ralph Stern Cardiovascular Medicine University of Michigan Ann Arbor, Michigan. stern@umich.
THE RISK DISTRIBUTION CURVE AND ITS DERIVATIVES Ralph Stern Cardiovascular Medicine University of Michigan Ann Arbor, Michigan stern@umich.edu ABSTRACT Risk stratification is most directly and informatively
More informationCrohn's disease and pregnancy.
Gut, 1984, 25, 52-56 Crohn's disease and pregnancy. R KHOSLA, C P WILLOUGHBY, AND D P JEWELL From the Gastroenterology Unit, Radcliffe Infirmary, Oxford SUMMARY Infertility and the outcome of pregnancy
More informationChapter 20: Analysis of Surveillance Data
Analysis of Surveillance Data: Chapter 20-1 Chapter 20: Analysis of Surveillance Data Sandra W. Roush, MT, MPH I. Background Ongoing analysis of surveillance data is important for detecting outbreaks and
More informationOET: Listening Part A: Influenza
Listening Test Part B Time allowed: 23 minutes In this part, you will hear a talk on critical illnesses due to A/H1N1 influenza in pregnant and postpartum women, given by a medical researcher. You will
More informationSpecimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing
Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing Overview Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are two of the most common sexually
More informationThe sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:
The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The good correlation allows close estimation of GFR Cystatin C GFR GFR in serum estimated* measured* n
More informationPregnancy-Related Deaths Due to Cardiomyopathy - Florida, 1999-2010
Pregnancy-Related Deaths Due to Cardiomyopathy - Florida, 1999-2010 THE FLORIDA PREGNANCY-ASSOCIATED MORTALITY REVIEW (FL-PAMR), 1999-2010 Funded through Title V MCH Block Grant FL-PAMR HISTORY In 1996,
More informationFirst Trimester Screening for Down Syndrome
First Trimester Screening for Down Syndrome What is first trimester risk assessment for Down syndrome? First trimester screening for Down syndrome, also known as nuchal translucency screening, is a test
More informationInterpretation of Somers D under four simple models
Interpretation of Somers D under four simple models Roger B. Newson 03 September, 04 Introduction Somers D is an ordinal measure of association introduced by Somers (96)[9]. It can be defined in terms
More informationSTATISTICA Formula Guide: Logistic Regression. Table of Contents
: Table of Contents... 1 Overview of Model... 1 Dispersion... 2 Parameterization... 3 Sigma-Restricted Model... 3 Overparameterized Model... 4 Reference Coding... 4 Model Summary (Summary Tab)... 5 Summary
More informationLothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy.
Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy. Early diagnosis and good management of maternal thyroid dysfunction is essential to ensure minimal adverse effects on
More informationRelationship between weight at puberty and mature weight in beef cattle
Relationship between weight at puberty and mature weight in beef cattle M.P. Davis and R.P. Wettemann STORY IN BRIEF The relationship between weight at puberty and mature weight was evaluated in Angus
More informationAnalytical goal setting in aneuploidy screening: within person biological variability of first trimester biochemical markers
DOI: 10.1002/pd.4019 ORIGINAL ARTICLE Analytical goal setting in aneuploidy screening: within person biological variability of first trimester biochemical markers Kevin Spencer* and Nicholas J. Cowans
More informationSOGC recommendation on ZIKA virus exposure for clinicians caring for pregnant women and those who intend to get pregnant
SOGC recommendation on ZIKA virus exposure for clinicians caring for pregnant women and those who intend to get pregnant Foreword The rapid emergence of Zika virus as a potential causative agent for fetal
More informationRegression Modeling Strategies
Frank E. Harrell, Jr. Regression Modeling Strategies With Applications to Linear Models, Logistic Regression, and Survival Analysis With 141 Figures Springer Contents Preface Typographical Conventions
More informationUltrasound Examinations Performed by Nurses in Obstetric, Gynecologic, and Reproductive Medicine Settings: Clinical Competencies and Education Guide
Ultrasound Examinations Performed by Nurses in Obstetric, Gynecologic, and Reproductive Medicine Settings: Clinical Competencies and Education Guide 3rd Edition The Association of Women s Health, Obstetric
More informationFecundability trends among sperm donors as a measure of donor performance
FERTILITY AND STERILITY VOL. 71, NO. 5, MAY 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Fecundability trends among
More informationAssisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register
1 Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register Joanne Gunby, M.Sc. CARTR Co-ordinator Email: gunbyj@mcmaster.ca Supported by the IVF Directors Group of
More informationPREGNANCY OF UNKNOWN LOCATION (PUL) - CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline
PREGNANCY OF UNKNOWN LOCATION (PUL) - CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline All clinical staff working in the Division of women, children & sexual health to provide evidence based guidance
More informationKeywords: Efficacy, Misoprostol Vaginal Administration, Pregnancy
A COMPARISON OF EFFICACY AND SIDE-EFFECTS OF TWO METHODS OF VAGINAL MISOPROSTOL ADMINISTRATION IN THE FIRST TRIMESTER OF PREGNANCY TERMINATION FOR PATIENTS OF BANDARABAS HOSPITAL LOCATED IN IRAN *Azadeaskari,
More informationEhlers-Danlos Syndrome Fertility Issues. Objectives
Ehlers-Danlos Syndrome Fertility Issues Baltimore Inner Harbor Independence Day Brad Hurst, M.D. Professor Reproductive Endocrinology Carolinas Medical Center - Charlotte, North Carolina Objectives Determine
More informationEastern Mediterranean Health Journal, Vol. 10, No. 3, 2004 437
Eastern Mediterranean Health Journal, Vol. 10, No. 3, 2004 437 Report Normal uterine size in women of reproductive age in northern Islamic Republic of Iran S. Esmaelzadeh, 1 N. Rezaei 1 and M. HajiAhmadi
More informationEffect of Risk and Prognosis Factors on Breast Cancer Survival: Study of a Large Dataset with a Long Term Follow-up
Georgia State University ScholarWorks @ Georgia State University Mathematics Theses Department of Mathematics and Statistics 7-28-2012 Effect of Risk and Prognosis Factors on Breast Cancer Survival: Study
More informationSupplementary online appendix
Supplementary online appendix 1 Table A1: Five-state sample: Data summary Year AZ CA MD NJ NY Total 1991 0 1,430 0 0 0 1,430 1992 0 1,428 0 0 0 1,428 1993 0 1,346 0 0 0 1,346 1994 0 1,410 0 0 0 1,410 1995
More informationWomen s Health Victoria
Women s Health Victoria Termination of Pregnancy Post 20 Weeks Background Paper March 2007 Prepared by Kerrilie Rice Policy and Research Officer Published by Level 1, 123 Lonsdale Street Melbourne Victoria
More informationA test your patients can trust. A company you know and trust.
A test your patients can trust. A company you know and trust. informaseq Prenatal Test an advanced, non-invasive, prenatal screening for T21, T18, and T13 chromosomal aneuploidies using next generation
More informationMethods for improvement of the success rate of artificial insemination with donor semen
INTERNATIONAL JOURNAL OFANDROLOGY 9 (1986) 14-2 Departments of Internul Medicine and Obstetrics, State University Hospital, Gent, Belgium Methods for improvement of the success rate of artificial insemination
More informationDrug Therapy Guidelines: Injectable Fertility Medications
Drug Therapy Guidelines: Injectable Fertility Medications Effective Date: 11/20/07 Committee Review Date: 7/12/00, 5/8/01, 1/15/02, 5/6/0, 12/16/0, 6/8/04, 12/16/05, 2/1/06, 10/15/06, 7/20/07, 11/5/07
More informationExploratory Factor Analysis of Demographic Characteristics of Antenatal Clinic Attendees and their Association with HIV Risk
Doi:10.5901/mjss.2014.v5n20p303 Abstract Exploratory Factor Analysis of Demographic Characteristics of Antenatal Clinic Attendees and their Association with HIV Risk Wilbert Sibanda Philip D. Pretorius
More informationAssessment and management of miscarriage
Assessment and management of miscarriage Dawn Miller is a Senior Lecturer in Women s Health at the Dunedin School of Medicine, University of Otago. She is also a doctor at Family Planning, Dunedin, and
More informationEvaluation and Follow-up of Fetal Hydronephrosis
Evaluation and Follow-up of Fetal Hydronephrosis Deborah M. Feldman, MD, Marvalyn DeCambre, MD, Erin Kong, Adam Borgida, MD, Mujgan Jamil, MBBS, Patrick McKenna, MD, James F. X. Egan, MD Objective. To
More informationThe following chapter is called "Follow-ups with a Positive or a Negative Pregnancy Test".
Slide 1 Welcome to chapter 7. The following chapter is called "Follow-ups with a Positive or a Negative Pregnancy Test". The author is Professor Pasquale Patrizio. Slide 2 This chapter has the following
More informationLEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD
LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD 2 Outline Genetics 101: Basic Concepts and Myth Busting Inheritance Patterns
More informationU.S. Teenage Pregnancy Statistics Overall Trends, Trends by Race and Ethnicity And State-by-State Information
U.S. Teenage Pregnancy Statistics Overall Trends, Trends by Race and Ethnicity And State-by-State Information The Alan Guttmacher Institute 120 Wall Street, New York, NY 10005 www.guttmacher.org Updated
More informationAuthors: Melissa Logsdon, M.P.H., Emily M. Godfrey, M.D., M.P.H., Arden Handler,
Authors: Melissa Logsdon, M.P.H., Emily M. Godfrey, M.D., M.P.H., Arden Handler, DrPH ABSTRACT Purpose: To determine women s preferences for the location of early abortion services. Description: Between
More informationSouth Dakota Task Force to Study Abortion Pierre, South Dakota September 21, 2005
South Dakota Task Force to Study Abortion Pierre, South Dakota September 21, 2005 Section III. : The review and exposition of the body of medical, psychological, and sociological knowledge that has accumulated
More informationSUMAN DUVVURU STAT 567 PROJECT REPORT
SUMAN DUVVURU STAT 567 PROJECT REPORT SURVIVAL ANALYSIS OF HEROIN ADDICTS Background and introduction: Current illicit drug use among teens is continuing to increase in many countries around the world.
More informationAn Application of the G-formula to Asbestos and Lung Cancer. Stephen R. Cole. Epidemiology, UNC Chapel Hill. Slides: www.unc.
An Application of the G-formula to Asbestos and Lung Cancer Stephen R. Cole Epidemiology, UNC Chapel Hill Slides: www.unc.edu/~colesr/ 1 Acknowledgements Collaboration with David B. Richardson, Haitao
More informationAdditional sources Compilation of sources: http://lrs.ed.uiuc.edu/tseportal/datacollectionmethodologies/jin-tselink/tselink.htm
Mgt 540 Research Methods Data Analysis 1 Additional sources Compilation of sources: http://lrs.ed.uiuc.edu/tseportal/datacollectionmethodologies/jin-tselink/tselink.htm http://web.utk.edu/~dap/random/order/start.htm
More informationDisparities in Realized Access: Patterns of Health Services Utilization by Insurance Status among Children with Asthma in Puerto Rico
Disparities in Realized Access: Patterns of Health Services Utilization by Insurance Status among Children with Asthma in Puerto Rico Ruth Ríos-Motta, PhD, José A. Capriles-Quirós, MD, MPH, MHSA, Mario
More informationInfertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups
Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups File name: Infertility Services File code: UM.REPRO.01 Last Review: 02/2016
More informationUltrasound in the First Trimester of Pregnancy. Elizabeth Lipson, HMS III
Ultrasound in the First Trimester of Pregnancy Elizabeth Lipson, HMS III First Trimester Sonography Localization of Gestational Sac Intrauterine vs. ectopic Identification of abnormalities Embryonic demise
More informationSAMPLE SIZE TABLES FOR LOGISTIC REGRESSION
STATISTICS IN MEDICINE, VOL. 8, 795-802 (1989) SAMPLE SIZE TABLES FOR LOGISTIC REGRESSION F. Y. HSIEH* Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, N Y 10461,
More informationMode and Patient-mix Adjustment of the CAHPS Hospital Survey (HCAHPS)
Mode and Patient-mix Adjustment of the CAHPS Hospital Survey (HCAHPS) April 30, 2008 Abstract A randomized Mode Experiment of 27,229 discharges from 45 hospitals was used to develop adjustments for the
More informationUltrasonography of the Fetal Thyroid
Article Ultrasonography of the Fetal Thyroid Nomograms Based on Biparietal Diameter and Gestational Age Angela C. Ranzini, MD, Cande V. Ananth, PhD, MPH, John C. Smulian, MD, MPH, Michelle Kung, Anita
More informationHealth disparities and infertility: impacts of state-level insurance mandates
Health disparities and infertility: impacts of state-level insurance mandates Marianne Bitler, Ph.D., a and Lucie Schmidt, Ph.D. b a Public Policy Institute of California, San Francisco, California, and
More informationEffect of incorrect gestational dating on Down s syndrome and neural tube risk assessment
Original Article Ann Clin Biochem 2001; 38: 230±234 Effect of incorrect gestational dating on Down s syndrome and neural tube risk assessment S N Millner From the Department of Pathology, University of
More informationCHAPTER THREE COMMON DESCRIPTIVE STATISTICS COMMON DESCRIPTIVE STATISTICS / 13
COMMON DESCRIPTIVE STATISTICS / 13 CHAPTER THREE COMMON DESCRIPTIVE STATISTICS The analysis of data begins with descriptive statistics such as the mean, median, mode, range, standard deviation, variance,
More informationClinical Studies Abstract Booklet
Clinical Studies Abstract Booklet The Harmony Prenatal Test is a non-invasive prenatal test (NIPT) that assesses the risk of trisomies by analyzing cell-free DNA (cfdna) in maternal blood. Since January
More informationClearblue Advanced Digital Ovulation Test
Clearblue Advanced Digital Ovulation Test Identifies a wider fertile window than any other ovulation test for more opportunities to get pregnant naturally Clearblue Professional Series About Clearblue
More informationZika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases
Zika Virus Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases What is the incubation period for Zika virus infection? Unknown but likely to be several
More informationArticle. Anthony O. Odibo, MD, Christopher Riddick, Emmanuelle Pare, MD, David M. Stamilio, MD, MSCE, George A. Macones, MD, MSCE
Article Cerebroplacental Doppler Ratio and Adverse Perinatal Outcomes in Intrauterine Growth Restriction Evaluating the Impact of Using Gestational Age Specific Reference Values Anthony O. Odibo, MD, Christopher
More informationASSESSING DECISION TREE MODELS FOR CLINICAL IN VITRO FERTILIZATION DATA
ASSESSING DECISION TREE MODELS FOR CLINICAL IN VITRO FERTILIZATION DATA Technical Report TR03 296 Dept. of Computer Science and Statistics University of Rhode Island LEAH PASSMORE 1, JULIE GOODSIDE 1,
More informationInsurance Reimbursement for Post-Pregnancy Long-Acting Reversible Contraception (LARC) Background Benefits of LARC
Insurance Reimbursement for Post-Pregnancy Long-Acting Reversible Contraception (LARC) Shandhini Raidoo MD, Bliss Kaneshiro MD, MPH, Mary Tschann MPH, Reni Soon MD, MPH, Emmakate Friedlander MD, Jennifer
More informationEuropean IVF Monitoring (EIM) Year: 2008
European IVF Monitoring (EIM) Year: 2008 Name of country POLAND Name and full address of contact person. professor Rafal Kurzawa MD PhD Fertility and Sterility Special Interest Group Polish Gynaecological
More informationMigration of an intrauterine contraceptive device to the sigmoid colon: a case report
The European Journal of Contraception and Reproductive Health Care 2003;8:229 232 Case Report Migration of an intrauterine contraceptive device to the sigmoid colon: a case report Ü. S. nceboz, H. T. Özçakir,
More informationTest Positive True Positive False Positive. Test Negative False Negative True Negative. Figure 5-1: 2 x 2 Contingency Table
ANALYSIS OF DISCRT VARIABLS / 5 CHAPTR FIV ANALYSIS OF DISCRT VARIABLS Discrete variables are those which can only assume certain fixed values. xamples include outcome variables with results such as live
More informationFamily Planning Curriculum
Family Planning Curriculum University of Alabama at Birmingham Department of Obstetrics and Gynecology Module 1: Introduction Incidence of unintended pregnancy and abortion Safety of abortion, morbidity
More informationConfidence Intervals for Spearman s Rank Correlation
Chapter 808 Confidence Intervals for Spearman s Rank Correlation Introduction This routine calculates the sample size needed to obtain a specified width of Spearman s rank correlation coefficient confidence
More informationSonographic Accuracy of Estimated Fetal Weight in Twins
ORIGINAL RESEARCH Sonographic Accuracy of Estimated Fetal Weight in Twins Lorie M. Harper, MD, MSCI, Kimberly A. Roehl, MPH, Methodius G. Tuuli, MD, MPH, Anthony O. Odibo, MD, MSCE, Alison G. Cahill, MD,
More information030 POSTGRADUATE COURSES
facebook.com/acognational MAY 4-8, 2013 ERNEST N. MORIAL CONVENTION CENTER SATURDAY, MAY 4 8:45 AM - 12:00 PM SATURDAY SA301 Recurrent First Trimester Pregnancy Loss - Classic and Cutting Edge Strategies**See
More informationRecent Progress in In Vitro Fertilization and Intracytoplasmic Sperm Injection Technologies in Japan
Research and Reviews Recent Progress in In Vitro Fertilization and Intracytoplasmic Sperm Injection Technologies in Japan JMAJ 52(1): 29 33, 2009 Kaoru YANAGIDA* 1 Abstract The three basic pillars of fertility
More informationDisclosure. Objectives 2/21/2016
Recurrent Pregnancy Loss: The myths, the controversies and the evidence Mamie McLean, MD Assistant Professor Reproductive Endocrinology and Infertility University of Alabama at Birmingham Disclosure I
More information